Achieve Life Sciences, Inc. (NASDAQ:ACHV) will be hosting a conference call at 4:30 PM eastern time on 12th November 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.achievelifesciences.com
The participants may dial, (877) 472-9809 Toll Free, (United States) or (629) 228-0791 (International), when prompted, enter passcode 8047128 in order to access the live audio call
Earnings Expectation
Achieve Life Sciences, Inc. is set to announce third quarter earning results on Thursday 12th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, ACHV to report 3Q20 loss of $ 1.31 per share. For the full year, analysts anticipate loss of $ 7 per share bottom line.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has a license agreement with Sopharma AD and University of Bristol.
